Allergen Challenge

Trial Profile

Allergen Challenge

Phase of Trial: Phase II

Latest Information Update: 11 Dec 2014

At a glance

  • Drugs Anrukinzumab (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 22 Jun 2008 Actual end date is May 2008 as reported by
    • 22 Jun 2008 Status changed from in progress to completed as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top